ClinicalTrials.gg
RecruitingNCT05807269Updated Aug 5, 2026

Prevention and Rehabilitation of Stroke in Uganda

An observational study in Stroke, sponsored by Karolinska Institutet. Recruiting at 2 sites in Uganda. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Karolinska Institutet · Observational

How we know

From the registry’s dates

  • Started Nov 2023; still recruiting 3 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
13 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Stroke by Karolinska Institutet — 3 open to participants now, 5 under way, none of them phase 3. Stroke · Karolinska Institutet.

Planned enrollment
9th of 11
50 · median 179
Started
2023
the only one that year
Observational
11 of 27
3 open now
Registered
24th of 27
by date

Among the 27 studies in Stroke by Karolinska Institutet, this one is the 9th largest by planned enrollment of the 11 observational ones that give a count, is the only one that started in 2023, is one of 11 observational ones, and was the 24th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

3 of the 27 studies in Stroke by Karolinska Institutet are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 13 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Stroke by Karolinska Institutet, or all of them as a file.
02

Study summary

Stroke is increasing in low-income countries in Africa, and knowledge is lacking on risk factors and how to prevent stroke as well as how to best use the resources for rehabilitation after stroke which are very limited. Knowledge generation within this area is therefore urgently needed. This collaboration between the research group HELD (Health and Everyday Life among people with neurological Disorders), Karolinska Institutet (KI) and the research surveillant site Africa Medical and Behavioral Sciences Organization (AMBSO) population health surveillance (PHS), will create substantial research opportunities to develop and improve prevention and rehabilitation for stroke, which is in line with the sustainable development goals to reduce the prevalence and mortality rates due to NCDs. AMBSO is collecting data from 17 000 households on many potential risk factors for stroke. Questions about stroke primary and secondary prevention of stroke and impact of stroke or need of rehabilitation could be added to the existing questionnaires such as the validated Ugandan version of the Stroke Impact Scale. This is intended to fulfill the aim of the network which is to increase the knowledge of occurrence and consequences of NCDs with a specific focus on stroke, which will be valuable for the development of preventive healthcare policy documents and guidelines for appropriate prevention strategies and rehabilitation interventions.

Research questions in relation to NCDs with focus on stroke prevention and rehabilitation:

  • How many cases (prevalence) are reported in the targeted study sites and what is the mortality rate (incidence) that can specifically relate to stroke?
  • How does stroke and other NCDs affect and impact the quality of life for persons living in Uganda?
  • Which factors impact the recovery process after stroke?
  • What sort of rehabilitation is needed in the study areas for persons affected by stroke? In addition, risk factors of stroke such as diabetes and hypertension will be mapped.
03

Conditions studied

  • Stroke

Browse trials for

04

Who can participate

Ages eligible
13 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Community sample from Wasiko and Hoima in Uganda

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Stroke
  • Risk factors for stroke: hypertension, diabetes, , malaria, physical inactivity, obesity

Exclusion criteria

Exclusion Criteria:

  • Not having had stroke and/or having no risk factor for stroke
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Groups and cohorts

  • People with stroke

    Participants with stroke or risk factors for stroke

06

What researchers measure

Primary outcomes

  1. Stroke Impact Scale-16

    Questionnaire comprising 16 statements concerning perceived impact of stroke. Each item is rated on a scale from 0 (high impact) to 5 (no impact).

    Time frame: At one assessment point during 2023-2024

  2. Stroke Impact Scale, perceived recovery

    Perceived recovery after stroke is rated on a visual analogue scale ranging from 0 (no recovery) to 100 (full recovery).

    Time frame: At one assessment point during 2023-2024

Secondary outcomes

  1. Life Satisfaction Checklist (LISat-11)

    Questionnaire that assesses life satisfaction with one global item "Life as a whole", and 9 domain-specific items. Answering alternatives range from 1 (very dissatisfied) to 6 (very satisfied)

    Time frame: At one assessment point during 2023-2024

  2. Patient Health Questionnaire-9

    Questionnaire with nine items that inquire about the frequency of depressed mood and anhedonia over the past two weeks. Score ranges from 0 (not at all) to 6 (nearly every day) where higher scores indicate higher frequency of depressed mood

    Time frame: At one assessment point during 2023-2024

  3. Generalized Anxiety Disorder Assessment-7

    A questionnaire assessing generalized anxiety disorder. The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions.

    Time frame: At one assessment point during 2023-2024

  4. Health Literacy Questionnaire

    Questionnaire that assesses health literacy. The Health Literacy Questionnaire contains 44 items, which are divided into nine areas of health literacy. The first five scales are scored on a 4-point Likert scale (ranging from strongly disagree to disagree, agree, and strongly agree), building part I. The other four scales, representing part II, are scored on a 5-point Likert scale where respondents are asked to rate the level of difficulty in undertaking a task (ranging from cannot do, always difficult, usually difficult, sometime difficult, usually easy, and always easy). Higher scores indicate better health literacy. In total six selected questions from part I and part II are used.

    Time frame: At one assessment point during 2023-2024

  5. Use of health care services

    Six questions on use of healthcare services, and information received on stroke and its consequences.

    Time frame: At one assessment point during 2023-2024

  6. Question about quality of life

    The respondents are asked to rate their quality of life on a on a five-point scale from 1 (very poor) to 5 (very good)

    Time frame: At one assessment point during 2023-2024

07

Study locations

2 of 2 sites recruiting
  • AMBSO, Hoima
    Hoima, Uganda
    Recruiting
    • Conrald Kalibagwa · Contact
  • AMBSO, Wakiso
    Kampala, Uganda
    Recruiting
    • Conrald Kalibagwa · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2023 (actual). Primary completion is estimated for Mar 2028, 52 months after the start.

Of 838 non-industry observational studies under Stroke, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 92. This study's planned 52 months is above that.

Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 13, 2023
First posted
Apr 11, 2023
StartActual
Nov 1, 2023
Primary completionEst.
Mar 31, 2028
CompletionEst.
Mar 31, 2028
Last update
Aug 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05807269
Collaborators
The Swedish Research Council
Responsible party
Gunilla Eriksson (Principal investigator, Karolinska Institutet) — Principal investigator
First posted
Apr 11, 2023
Start date
Nov 1, 2023
Primary completion
Mar 31, 2028 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Aug 5, 2026

Study contacts

Gunilla Eriksson, PhD
Contact
gunilla.eriksson@ki.se
+46702216924
Gunilla Eriksson, PhD
principal investigator · Karolinska Institutet

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion